New Current Report Filed with the SEC: 8-K – OptimizeRx Corp (0001448431) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC). Details of the current report are:

8-K – OptimizeRx Corp (0001448431) (Filer)
Filed: 2015-09-30 AccNo: 0001213900-15-007373 Size: 515 KB

Item 1.01: Entry into a Material Definitive Agreement

Item 3.02: Unregistered Sales of Equity Securities

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item 8.01: Other Events

Item 9.01: Financial Statements and Exhibits
Filing Date: 2015-09-30T09:10:47-04:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: